ETFs
V
VRDN
Viridian Therapeutics Inc
22.23
+1.43+6.88%Opening13:02 10/20 EDT
OPEN/PREV CLOSE21.10/20.80
TODAY RANGE20.85-22.33
VOL902.54K
MARKET CAP2.52B
52 WEEK RANGE13.18-34.29
AVG VOL (3M)1.79M
% TURNOVER0.80%
TURNOVER--
P/E (TTM)-5.6978
% RANGE7.12%
EPS(TTM)-3.9015
P/E(FORWARD)-5.6090
P/B3.802
BVPS5.85
DIVIDEND--
P/S31.95
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.50B
SHARES OUTSTANDING113.29M
NEXT EARNINGS11/03-11/09
FREE FLOAT112.51M
LOT SIZE1
EX-DATE11/13/2020
News
Press Releases
Financial Reports
Profile
TipRanks·10/09 01:48
RBC Capital Keeps Their Buy Rating on Viridian Therapeutics (VRDN)
Seeking Alpha·10/05 15:59
These healthcare stocks stand out with A+ growth grades
TipRanks·10/03 01:50
Wall Street Analysts Are Bullish on Top Healthcare Picks
Dow Jones·09/22 13:42
Viridian Therapeutics Is Maintained at Outperform by RBC Capital
TipRanks·09/22 11:30
Viridian Therapeutics price target raised to $38 from $36 at RBC Capital
Seeking Alpha·09/17 14:46
Viridian Therapeutics: Two Products, One Commercial Buildout
TipRanks·08/13 15:36
Stifel Nicolaus Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)
TipRanks·08/13 02:26
Viridian Therapeutics (VRDN) Gets a Buy from Truist Financial
TipRanks·08/10 12:45
Viridian Therapeutics (VRDN) Receives a Buy from Evercore ISI
Same Industry
Name/Symbol
Change%
Price